New Life Rheumatology Center LLC
New Life Rheumatology Center LLC was paid $518K by Medicaid between Jan 2018 and Sep 2019, across 30 billing codes. Its largest line is J7324, Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose — 24% of everything it billed.
33Billing provider infoNEW LIFE RHEUMATOLOGY CENTER LLC
CLIFTON, NJ 07012
CLIFTON, NJ 07012
33aNPI1356505127assigned 07/11/2008
33bProvider typeSpecialist
28Total paid$518K
24GClaims17,799
24DCodes billed30
24AFirst – last monthJan 2018 – Sep 2019
Compared with peers
Next to other Specialist providers in New Jersey
Rank by total paid#87 of 378
Median peer was paid$63K
This provider vs. median8.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,730 | $270K | |
| 2019 | 8,069 | $248K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 24% | 1,000 | 539 | $122K |
| 96401 | 18% | 3,565 | 1,759 | $93K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 3,833 | 2,573 | $91K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 2,011 | 1,738 | $86K |
| 20610 | 7.5% | 2,144 | 1,278 | $39K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.0% | 1,151 | 731 | $16K |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 2.4% | 154 | 85 | $12K |
| 99205 | Prolong outpt/office vis | 1.9% | 99 | 99 | $10K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.8% | 139 | 131 | $9K |
| J0897 | Injection, denosumab, 1 mg | 1.5% | 55 | 55 | $8K |
| 76881 | 1.4% | 363 | 329 | $7K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.2% | 29 | 28 | $6K |
18 more codes
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 627 | $4K |
| 77080 | <1% | 123 | $2K | |
| 99245 | <1% | 13 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 35 | $1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 409 | $1K |
| 92548 | <1% | 34 | $1K | |
| J9260 | Injection, methotrexate sodium, 50 mg | <1% | 1,366 | $1K |
| 93922 | <1% | 28 | $1K | |
| 95923 | <1% | 15 | $870.05 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 185 | $859.35 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $823.13 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 17 | $743.24 |
| 95117 | <1% | 116 | $666.10 | |
| 95943 | <1% | 15 | $631.63 | |
| 76882 | <1% | 16 | $290.59 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 183 | $159.61 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 46 | $116.94 |
| 36000 | <1% | 16 | $22.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHU, ALICE (RHEUMATOLOGYST)